Autoantibodies in Autoimmune Hepatitis (AIH)
13 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What are LKM antibodies and their significance in AIH?

LKM antibodies target cytochrome P450 isoenzyme CYP2D6 and are primarily found in children and young adults with AIH, indicating a potentially more aggressive disease course.

How do autoantibody titres relate to disease activity in AIH?

Autoantibody titres often do not correlate with disease activity, suggesting that their presence may not directly contribute to liver damage in AIH.

What is the role of SLA/LP antibodies in AIH, particularly concerning their presence in newborns?

SLA/LP antibodies have been found in breast milk and serum of healthy newborns of AIH-positive mothers, suggesting they do not directly cause liver injury.

What are the implications of finding liver cytosolic antibodies type 1 (LC1) in AIH?

<p>LC1 antibodies, which target the enzyme FTCD, are highly specific for type 2 AIH, indicating distinct autoantibody profiles in AIH subtypes.</p> Signup and view all the answers

Why is further research on autoantibodies important for AIH?

<p>Further research is needed to better understand how autoantibodies contribute to AIH development, which may lead to targeted therapies addressing the underlying immune dysfunction.</p> Signup and view all the answers

What is the prevalence range of Antinuclear Antibodies (ANA) in patients with autoimmune hepatitis (AIH)?

<p>ANA is present in 50-70% of patients with AIH.</p> Signup and view all the answers

Explain the significance of high titres of Anti-dsDNA antibodies in the context of AIH.

<p>High levels of Anti-dsDNA antibodies are specific for AIH and confirm the diagnosis when present with inflammatory liver disease.</p> Signup and view all the answers

What role do Smooth Muscle Antibodies (SMA) play in diagnosing AIH?

<p>SMA is found in 50-70% of AIH patients and high titres suggest an autoimmune disease, especially in young individuals.</p> Signup and view all the answers

Discuss the relationship between Soluble Liver Antigen/Liver Pancreas (SLA/LP) antibodies and AIH.

<p>SLA/LP antibodies are highly specific for AIH but present in only about 20% of patients.</p> Signup and view all the answers

How do the titres of ANA and SMA fluctuate in relation to disease activity in AIH?

<p>ANA titres can fluctuate with disease activity, while SMA titres, especially in children, are consistent with autoimmune diseases.</p> Signup and view all the answers

Why is testing for subtypes of ANA generally considered not useful in AIH?

<p>Testing for subtypes of ANA is generally not useful in AIH, except for antibodies against double-stranded DNA.</p> Signup and view all the answers

What is debated regarding SLA/LP-positive patients in the context of AIH?

<p>There is debate about whether SLA/LP-positive patients should be classified as a distinct subtype of AIH, referred to as 'type 3 AIH.'</p> Signup and view all the answers

Describe how the presence of both ANAs and SMAs assists in the diagnosis of AIH.

<p>The presence of both ANAs and SMAs, along with elevated liver enzymes, is highly suggestive of AIH.</p> Signup and view all the answers

Study Notes

Autoantibodies in Autoimmune Hepatitis (AIH)

  • Autoantibodies are crucial in diagnosing and understanding AIH.
  • ANAs are the most common, present in 50-70% of AIH patients.
  • ANAs react with cell nucleus components, but the exact staining patterns do not always clinically correlate.
  • High ANA titres are important in autoimmune diseases like AIH.
  • ANA titres might fluctuate with disease progression, but are not routinely monitored.
  • Subtypes like ENAs are generally unhelpful, except for anti-dsDNA.
  • Anti-dsDNA is highly specific for AIH and SLE.
  • SMA are also common (50-70%), reacting with smooth muscle components.
  • High titres especially in young adults are suggestive of AIH.
  • Positivity for ANA and SMA with elevated liver enzymes strongly suggests AIH.
  • SLA/LP are highly specific (20% prevalence).
  • SLA/LP targets a selenocysteine synthesis enzyme.
  • Positive SLA/LP virtually confirms AIH, but absence does not rule it out.
  • SLA/LP titres do not necessarily correlate with disease severity.
  • SLA/LP-positive patients might have more severe AIH, needing more frequent treatment.
  • LKM antibodies are linked with type 2 AIH, typically found in children/young adults (up to 10% of children and <3% of adults).
  • LKM attacks a CYP2D6 cytochrome P450 isoenzyme .
  • LKM-positive AIH often exhibits a more aggressive form (type 2).
  • LC1 antibodies target FTC, specific marker for type 2 AIH.
  • pANCAs can be observed, but less specific and more common in PSC.
  • Antibodies against Ro52 are associated with SLA/LP in AIH presence.

Unanswered Questions and Future Directions

  • The exact role of autoantibodies in AIH pathogenesis is still poorly understood.
  • Observations like SLA/LP presence in breast milk or lack of correlation between titres & disease activity, question the direct pathogenic role of these antibodies.
  • Further research is needed to fully understand the mechanisms implicated in AIH development and progression, paving the way for more targeted treatments.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Description

This quiz explores the role of autoantibodies in diagnosing and understanding autoimmune hepatitis (AIH). It covers various autoantibodies, their prevalence, and their clinical significance, including ANAs and SMAs. Understanding these markers is crucial for proper diagnosis and treatment of AIH.

More Like This

Use Quizgecko on...
Browser
Open
Browser
Browser